A carregar...
Dual antiplatelet therapy for secondary prevention of coronary artery disease
Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y(12) receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) for stable coronary art...
Na minha lista:
| Publicado no: | Open Heart |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652612/ https://ncbi.nlm.nih.gov/pubmed/29081979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000651 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|